Skip to content
Search

Latest Stories

GPhC publishes new initial education and training standards for pharmacists

The General Pharmaceutical Council (GPhC) has published its new initial education and training standards for pharmacists which will be gradually implemented from this year onwards.

The regulator believes the changes made to the 2011 standards will allow a new breed of pharmacists to play a much greater role in providing clinical care to patients from their first day on the register, including through prescribing medicines.


The new document reflects "a shift across Great Britain towards integrated health and social care" and recognises "a move for patient care to be delivered in the right setting at the right time".

"These new standards will enable pharmacists to better fulfil their roles as medicines experts and realise their potential as independent prescribers," said Gail Fleming, RPS director for education and professional development, responding to the changes.

“We are delighted that the standards reflect the same domains used in post-registration, which supports a structured and seamless approach to the development of a pharmacist’s career, from initial education and training through to consultant level practice," Fleming added.

The changes outlined in the standards also include improvements relating to equality, diversity and fairness "to combat discrimination and deal with health inequalities".

The GPhC hopes these standards will produce adaptable pharmacists who will be:

• confident about and capable of operating in multi-professional teams across a variety of healthcare settings to meet diverse and changing patient needs

• dedicated to person-centred care, both in person and through remote consultations. They will ensure the high-quality use of medicines that incorporates both safety and effectiveness alongside compassion and empathy, and

• proficient prescribers whose skills can be used to collaborate with and support the wider, complex healthcare systems across Great Britain and Northern Ireland.

The pharmacy regulator's new standards set out what knowledge, skills, understanding and professional behaviours a student or trainee pharmacist must demonstrate to pass their initial education and training and to join the professional register.

The standards ensure that newly registered pharmacists are competent enough to practise safely and effectively. Additionally, they also set out requirements for organisations providing initial education and training.

Fleming concluded: “It’s essential that the necessary additional funding is provided for these standards, so they can be implemented correctly. We look forward to continuing our work with the GPhC and other stakeholders to ensure that students can fully see how this will affect their learning over the coming years.”

More For You

Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less
Pharmacies in Northern Ireland distribute free booklets to raise cancer awareness

Dr Anna Cullen, Public Health Registrar at the Public Health Agency and Clare Conroy, Community Pharmacist from Meigh Pharmacy in Co Down.

Photo credit: Community Pharmacy Northern Ireland

Pharmacies in Northern Ireland help raise cancer awareness

Community pharmacies across Northern Ireland are distributing a free information booklet to help raise public awareness of the signs and symptoms of cancer and promote early diagnosis.

The initiative is part of the ‘Be Cancer Aware’ campaign, which has been running in pharmacies since April and will continue through May as part of the Living Well service.

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less